FDA inspection
Balin, Martin S., MD, PhD: FDA inspection ending Aug 17, 2012
FDA inspection 787333 · Official Action Indicated (OAI) · Chicago, IL
Key facts
| Inspection ID | 787333 |
|---|---|
| Firm | Balin, Martin S., MD, PhD |
| FEI number | 3005919692 |
| Address | 409 W Huron St Fl 5 |
| City | Chicago |
| State | IL |
| ZIP | 60654 |
| Country | United States |
| Fiscal year | 2012 |
| Inspection end date | Aug 17, 2012 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
| Warning letter | 353578 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data